EDSS improvement: recovery of function or noise?

被引：6

作者：

Ontaneda, Daniel ^{[1
]}

Cohen, Jeffrey A. ^{[1
]}

机构：

[1] Cleveland Clin, Mellen Ctr, Dept Neurol, Cleveland, OH USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷 / 11期

关键词：

DISABILITY STATUS SCALE; RATING NEUROLOGIC IMPAIRMENT; MULTIPLE-SCLEROSIS; MS;

D O I：

10.1177/1352458512441689

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1520 / 1521

页数：2

共 11 条

[1] Disability as an outcome in MS clinical trials [J].

Ebers, G. C. ;

Heigenhauser, L. ;

Daumer, M. ;

Lederer, C. ;

Noseworthy, J. H. .

NEUROLOGY, 2008, 71 (09) :624-631

[2] INTERRATER AND INTRARATER SCORING AGREEMENT USING GRADES 1.0 TO 3.5 OF THE KURTZKE EXPANDED DISABILITY STATUS SCALE (EDSS) [J].

GOODKIN, DE ;

COOKFAIR, D ;

WENDE, K ;

BOURDETTE, D ;

PULLICINO, P ;

SCHEROKMAN, B ;

WHITHAM, R ;

JACOBS, L ;

MUNSCHAUER, F ;

EMRICH, L ;

GRANGER, C ;

HERNDON, R ;

RUDICK, R ;

FISCHER, J ;

SIMON, J ;

SALAZAR, A .

NEUROLOGY, 1992, 42 (04) :859-863

[3] Kurtzke scales revisited: the application of psychometric methods to clinical intuition [J].

Hobart, J ;

Freeman, J ;

Thompson, A .

BRAIN, 2000, 123 :1027-1040

[4] A method for estimating normative distributions for study-specific populations of clinical trials [J].

Holmes, Tyson H. ;

Nichols, Deborah A. ;

Thomander, Darryl ;

Kushida, Clete A. .

CONTEMPORARY CLINICAL TRIALS, 2012, 33 (02) :445-449

[5] COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

JOHNSON, KP ;

BROOKS, BR ;

COHEN, JA ;

FORD, CC ;

GOLDSTEIN, J ;

LISAK, RP ;

MYERS, LW ;

PANITCH, HS ;

ROSE, JW ;

SCHIFFER, RB ;

VOLLMER, T ;

WEINER, LP ;

WOLINSKY, JS ;

BIRD, SJ ;

CONSTANTINESCU, C ;

KOLSON, DL ;

GONZALEZSCARANO, F ;

BRENNAN, D ;

PFOHL, D ;

MANDLER, RN ;

ROSENBERG, GA ;

JEFFREY, C ;

BARGER, GR ;

GANDHI, B ;

MOORE, PM ;

ROGERS, LR ;

LISAK, D ;

SMITH, L ;

ELLISON, GW ;

BAUMHEFNER, RW ;

CRAIG, SL ;

JALBUT, SS ;

KATZ, E ;

CONWAY, KL ;

BURNS, JB ;

SHIBA, C ;

GIANG, DW ;

PETRIE, MD ;

GUARNACCIA, JB ;

ANDERSON, S ;

MCKEON, A ;

MCCARTHY, M ;

THOMAS, AB ;

VRIESENDORP, FJ ;

AUSTIN, SG ;

LINDSEY, JW ;

DIMACHKIE, M ;

CERRETA, E ;

KACHUCK, N ;

MCCARTHY, KA .

NEUROLOGY, 1995, 45 (07) :1268-1276

[6] Disease progression in multiple sclerosis: combining physicians' and patients' perspectives? [J].

Kragt, J. J. ;

Nielsen, J. M. ;

van der Linden, F. A. H. ;

Polman, C. H. ;

Uitdehaag, B. M. J. .

MULTIPLE SCLEROSIS, 2011, 17 (02) :234-240

[7]

KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444

[8] Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis [J].

Phillips, J. Theodore ;

Giovannoni, Gavin ;

Lublin, Fred D. ;

O'Connor, Paul W. ;

Polman, Chris H. ;

Willoughby, Ernie ;

Aschenbach, William ;

Pace, Amy ;

Hyde, Robert ;

Munschauer, Frederick E. .

MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (08) :970-979

[9] Are quantitative functional measures more sensitive to worsening MS than traditional measures? [J].

Schwid, SR ;

Goodman, AD ;

Apatoff, BR ;

Coyle, PK ;

Jacobs, LD ;

Krupp, LB ;

Miller, AE ;

Wende, KE ;

Brownscheidle, CM .

NEUROLOGY, 2000, 55 (12) :1901-1903

[10] Natural, innate improvements in multiple sclerosis disability [J].

Tremlett, Helen ;

Zhu, Feng ;

Petkau, John ;

Oger, Joel ;

Zhao, Yinshan .

MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (10) :1412-1421

← 1 2 →